NL-OMON53785招募中不适用
Proteomics and genomics combined with CT to predict CVD - PREDICT-CVD
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Adult subjects between 50 and 75 years old.
- •- Subjects at intermediate to high risk for ASCVD
- •- Asymptomatic subjects without cardiac chest pain
- •- Evidence of atherosclerosis on baseline CCTA
排除标准
- •- Renal insufficiency, defined as eGFR < 30 ml/min
- •- History of cardiovascular events (myocardial infarction, peripheral artery
- •disease and ischemic stroke)
- •- Use of lipid lowering therapy other than statin, ezetimibe or bempedoic acid
- •monotherapy
- •- Change in lipid lowering therapy in the last 6 months
- •- Use of more than two antihypertensive agents
- •- No coronary atherosclerosis at baseline imaging
- •- Active malignancy requiring treatment
- •- Atrial fibrillation
- •- Any other treatment or clinically relevant condition that could interfere
- •with the conduct or interpretation of the study in the opinion of the
- •investigator
- •- Inability or unwillingness to comply with the protocol requirements, or
- •deemed by investigator to be unfit for the study.
研究者
相似试验
招募中
不适用
The use of novel protein biomarkers in predicting clinical outcomes in patients with localised and metastatic colorectal cancerColorectal cancerACTRN12610000776000Cancer Institute NSW200
已完成
不适用
Proteomic analysis for establishing a biomarker panel for the onset of Adult T-cell Leukemia (ATL)JPRN-UMIN000038467niversity of the Ryukyus85
尚未招募
不适用
Application of proteomics to aid biomarker discovery in smear positive patients of P.vivax and P.falciparum malariaCTRI/2010/091/000451Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), Powai, Mumbai- 400 076100
尚未招募
Unknown
How Predictive Factors Influence Treatment Outcomes in HPV-negative Oral Cancer Patients After neoadjuvant chemotherapyCTRI/2024/04/066506Tata Memorial Centre
已完成
不适用
Study of proteomics for identification of novel prognostic biomarkers in patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma undergoing surgical resectioHepatocellular carcinoma and Intrahepatic cholangiocarcinomaHepatocellular carcinoma, Intrahepatic cholangiocarcinoma, Biomarkers, Proteomics, PrognosisTCTR20220113002Ratchadapisek Research Funds115